Gynesonics gets $2 million from Hercules

By Elaine Rigoli

Tampa, Fla., Sept. 19 - Hercules Technology Growth Capital, Inc. provided $2 million of debt financing to Gynesonics, Inc., a developer of minimally invasive treatments for uterine fibroid tumors.

The Palo Alto, Calif., development-stage company was founded in 2005 by Jessica Grossman, who recognized the need for a treatment for uterine fibroids that solves the problems of general anesthesia, long recovery times and infertility.

Issuer:	Gynesonics, Inc.
Issue:	Debt financing
Amount:	$2 million
Investors:	Hercules Technology Growth Capital, Inc.
Announcement date:	Sept. 19

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.